 This statistic depicts the global revenue of Seretide/Advair around the world from 2012 to 2018, by region. Seretide/Advair generated a revenue of 1.83 billion British pounds in 2016 in the United States alone. Advair is the brand name marketed in the U.S. and Canada but is known as Seretide in many other countries. This pharmaceutical product is used to treat asthma through a combination of a preventer inhaler and a symptom controller. 